No severe flares after mRNA vaccination of rheumatology patients: study
The data from nearly 1400 US patients should allay patients' fears, researchers say
In patients with rheumatological and musculoskeletal diseases, vaccination against COVID-19 with an mRNA vaccine does not seem to increase the risk of severe flares, researchers say.
The finding should allay any patient concerns that vaccination could make their condition worse, they say.
US researchers evaluated disease flare and reactogenicity in 1377 patients with rheumatological and musculoskeletal diseases who had received two doses of a COVID-19 mRNA vaccine between mid-December 2020 and mid-April 2021.
More than half (55%) were inoculated with the Pfizer-BioNTech vaccine and the rest had the Moderna vaccine, the authors reported in Arthritis and Rheumatology.
